(Q52732360)

6 May 2018

title

Statistical power in biological psychiatry (English)

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90072-X

20 August 2023

0 references

0 references

A. B. Rothpearl

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6172806

20 August 2023

R. C. Mohs

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6172806

20 August 2023

K. L. Davis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6172806

20 August 2023

language of work or name

English

0 references

publication date

1 December 1981

1 reference

6 May 2018

full work available at URL

https://api.elsevier.com/content/article/PII:016517818190072X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90072-X

https://api.elsevier.com/content/article/PII:016517818190072X?httpAccept=text/plain

20 August 2023

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90072-X

20 August 2023

1 reference

6 May 2018

volume

5

1 reference

6 May 2018

issue

3

1 reference

6 May 2018

page(s)

257-266

1 reference

6 May 2018

Changes on recovery in the concentrations of tryptophan and the biogenic amine metabolites in the cerebrospinal fluid of patients with affective illness

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90072-X

5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases.

20 August 2023

2

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90072-X

Correlation between cerebrospinal fluid amine metabolites and psychomotor activity in affective disorders

20 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90072-X

CSF monoamine metabolites in depression and schizophrenia

20 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90072-X

Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in psychiatric patients

20 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90072-X

Response to dexamethasone and subtype of depression

20 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90072-X

Biologic heterogeneity and psychiatrict research. Platelet MAO activity as a case study

20 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90072-X

Neuroendocrine regulation in depression. I. Limbic system-adrenocortical dysfunction.

20 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90072-X

Neuroendocrine regulation in depression. II. Discrimination of depressed from nondepressed patients.

20 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90072-X

Abnormalities of indoleamines in affective disorders.

20 August 2023

15

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90072-X

Acid monoamine metabolites of cerebrospinal fluid in mental depression and mania

20 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90072-X

Studies on sodium transfer and 5-hydroxyindoles in depressive illness

20 August 2023

17

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90072-X

Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique.

20 August 2023

18

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90072-X

Effect of ECT and imipramine treatment on the concentration of 5-hydroxyindoleacetic acid (5HIAA) and homovanillic acid (HVA) in the cerebrospinal fluid of depressed patients

20 August 2023

19

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90072-X

Homovanillic and 5-Hydroxyindoleacetic Acid in Cerebrospinal Fluid of Depressed Patients

20 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90072-X

Central Norepinephrine Metabolism in Affective Illness: MHPG in the Cerebrospinal Fluid

20 August 2023

22

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90072-X

Hypothalamic-pituitary-adrenal axis activity in depressive illness. Its relationship to classification

20 August 2023

24

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90072-X

3-Methoxy-4-hydroxyphenylglycol in depression

20 August 2023

25

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90072-X

Role of biogenic amines in certain pathological conditions

20 August 2023

27

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90072-X

CSF monoamine metabolites in alcoholism: a comparative study with depression

20 August 2023

28

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90072-X

20 August 2023

Q64972062

29

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90072-X

Biogenic amine metabolites in cerebrospinal fluid of patients with affective disorders

20 August 2023

30

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90072-X

Cerebrospinal Fluid Levels of MHPG in Affective Disorders

20 August 2023

31

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90072-X

20 August 2023

Identifiers

1 reference

6 May 2018

1 reference

6 May 2018